Symonds Toby Edgcumbe 4

What Happened Toby Edgcumbe Symonds, President of IPERIONX Ltd (IPX), received three derivative equity grants on April 2, 2026 totaling 1,369,812 awards: 226,047; 536,521; and 607,244. The filing shows these are derivative instruments (options and/or performance rights) with no cash price reported (N/A), meaning they are awards rather than open‑market purchases or sales.

Key Details

• Transaction date: 2026-04-02; filing date / period of report: 2026-04-02 (filed same day).
• Awards granted: 226,047; 536,521; 607,244 — total 1,369,812 derivative awards.
• Price / value: N/A in the filing (these are grants, not purchases at a set market price).
• Vesting / conversion notes from the filing:
  • Some awards have time-based vesting: 302,666 vest in Dec 2026; 400,533 vest in Apr 2028 (per footnote).
  • Performance right conditions include four years of continuous service through 04/02/2030 and an ASX 30‑day VWAP of A$18 (per footnote).
  • Options (where applicable) confer the right to purchase one ordinary share at the stated conversion price.
• Trading venues and units:
  • Ordinary shares trade on the Australian Securities Exchange (ASX).
  • American Depositary Shares (ADS) trade on Nasdaq; 1 ADS = 10 ordinary shares.
  • Monetary references in the filing are in Australian Dollars (A$).
• Shares owned after transaction: not specified in the provided filing summary.
• Timeliness: filing appears timely (filed same day as the transaction).

Context These are compensation grants (derivative awards like performance rights or options) rather than open‑market purchases or sales. Such awards vest or convert only if time and/or performance conditions are met, so they do not represent an immediate cash outlay or sale by the insider. For retail investors, grants signal executive compensation alignment with future performance targets but should not be interpreted as an immediate bullish market signal.